-
19 September 2023
Global Fund, Stop TB Partnership and USAID Announce New Collaboration with Danaher to Reduce Price and Increase Access to Cepheid’s TB Test
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) announced today a new collaboration with Danaher Corporation (Danaher), a global science and technology innovator who will provide Cepheid’s Xpert® MTB/RIF Ultra diagnostic tes... -
18 September 2023
Climate Change and Conflict Slow Down Progress Despite Record Results
The Global Fund’s 2023 Results Report released today shows a remarkable acceleration of programmatic results in the fight against HIV, TB and malaria, after losses from the COVID-19 pandemic. However, multiple challenges, including climate change and... -
30 August 2023
Global Fund Agreements Substantially Reduce the Price of First-line HIV Treatment to Below US$45 a Year
Through its competitive tenders, the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), together with its partners and generic pharmaceutical manufacturers, will be able to offer tenofovir disoproxil fumarate, lamivudine and dolut... -
22 August 2023
Global Fund Announces New Mechanism to Increase Access to More Effective Mosquito Nets to Prevent Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) is launching a new Revolving Facility to negotiate improved supply terms for global health products for the countries it supports. This financial mechanism uses advanced market... -
08 August 2023
Global Fund, PEPFAR and Unitaid Collaboration Paves Way to Accelerate Approval of African-Manufactured HIV Rapid Tests
The Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Unitaid are partnering to accelerate the manufacturing of health products in Africa, with HIV rapid diagnostic... -
18 July 2023
Global Fund, GSK and ViiV Healthcare Strengthen Their Partnership for Gender Equality
The Global Fund to Fight AIDS, Tuberculosis and Malaria applauds GSK and ViiV Healthcare’s combined commitment of US$7.5 million over three years for the Gender Equality Fund, which will help accelerate progress towards gender equality through commun...